Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry

PHASE3CompletedINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

July 2, 2019

Study Completion Date

July 2, 2019

Conditions
Diabetes Mellitus, Type 2Left Ventricular Systolic Dysfunction
Interventions
DRUG

Linagliptin

DRUG

Placebo

Trial Locations (19)

10023

Ospedale Maggiore, Chieri

10128

Ospedale Mauriziano, Torino

12100

A.O. Santa Croce e Carle, Cuneo

16035

Iclas-Istituto Clinico Ligure Alta Spec., Rapallo

16149

Ospedale Villa Scassi, Genova

20010

Ospedale San Raffaele, Milan

20099

Irccs Policlinico Multimedica, Sesto San Giovanni

20138

Centro Cardiologico Monzino, Milan

24127

Azienda Ospedaliera Papa Giovanni Xxiii, Bergamo

34148

Aas 1 Triestina, Trieste

38100

Casa di Cura Villa Bianca, Trento

71013

Ospedale Casa Sollievo Della Sofferenza, San Giovanni Rotondo

73043

Ospedale San Giuseppe Da Copertino, Copertino

80131

Aorn Osp. Dei Colli- Po Vincenzo Monaldi, Napoli

Seconda Universita' Di Napoli, Napoli

95122

P.O. Garibaldi-Nesima, Catania

98124

Policlinico G. Martino, Messina

00157

Ospedale Sandro Pertini, Roma

05100

Azienda Ospedaliera Santa Maria, Terni

Sponsors
All Listed Sponsors
collaborator

Fondazione dell'Associazione Medici Diabetologi

UNKNOWN

lead

Heart Care Foundation

OTHER

NCT02851745 - Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry | Biotech Hunter | Biotech Hunter